Tag Archives: Biogen

VHA Will Provide Coverage for Leqembi to Qualified Veterans with Early Alzheimer’s Disease

VHA Will Provide Coverage for Leqembi to Qualified Veterans with Early Alzheimer’s Disease, while the CMS continues to restrict its use

JNJ’s Multiple Sclerosis Drug Ponvory Available From Covance Specialty Pharmacy

The Janssen Pharmaceutical Companies of Johnson & Johnson recently announced that the FDA approved PONVORY™ (ponesimod), a once-daily oral selective sphingosine-1-phosphate receptor 1 (S1P1) modulator, to treat adults with relapsing forms of multiple sclerosis (MS). PONVORY™ offers MS patients superior efficacy in reducing annualized relapse rates compared to an established oral therapy and a proven […]